Al-Nafussi A. Spindle cell tumours of the breast: practical approach to diagnosis. Histopathology 1999; 35: 1-13. Anderson TJ, Page DL. Risk assessment in breast cancer. In: Anthony PP, MacSween RNM (eds). Recent advances in histopathology 17. Churchill Livingstone. Edinburgh 1997; 69-91.
Bloom HJG, Richardson WW. Histological grading and prognosis in breast carcinoma: a study of 1049 cases of which 359 have been followed for 15 years. Br J Cancer 1957; 11: 359-377.
Boecker W, Buerger H. Usual and atypical ductal hyperplasia—members of the same family? Curr Diagn Pathol 2004; 10: 175-182.
Cserni G. A model for determining the optimum histology of the sentinel lymph nodes in breast cancer. J Clin Pathol 2004; 57: 467-471.
Dahlstrom JE, Sutton S, Jain S. Histological precision of stereotactic core biopsy in diagnosis of malignant and premalignant breast lesions. Histopathology 1996; 29: 537-541.
Dixon M. ABC of breast diseases, 2nd edn. BMJ Books. London 2000.
Douglas-Jones AG, Gupta SK, Attanoos RL, Morgan JM, Mansel RE. A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma. Histopathology 1996; 29: 397-409.
Ellis IO, Bartlett J, Dowsett M, Humphreys S, Jasani B, Miller K, Pinder SE, Rhodes A, Walker R. Updated recommendations for HER2 testing in the UK. Best Practice No 176. J Clin Pathol 2004; 57: 233-237.
Ellis IO, Humphreys S, Michell M, Pinder SE, Wells CA, Zakhour HD. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment. Best Practice No 179. J Clin Pathol 2004; 57: 897-902.
Elston CW, Ellis IO. Pathological prognostic factors in breast cancer: experience from a long study with long-term follow-up. Histopathology 1991; 19: 403-410.
Elston CW, Ellis IO (eds). The Breast. Systemic Pathology, 3rd edn. Vol. 13. Churchill Livingstone. Edinburgh 1998.
Fitzgibbins PL, Page DL, Weaver D et al. Prognostic factors in breast cancer. College of American Pathologists consensus statement 1999. Arch Pathol Lab Med 2000; 124: 966-978.
Fulford LG, Reis-Filho JS, Lakhani SR. Lobular in-situ neoplasia. Curr Diagn Pathol 2004; 10: 183-192.
Harris G, Pinders S, Ellis I. Ductal carcinoma in-situ: diagnosis and classification. Curr Diagn Pathol 2004; 10: 204-210.
Kennedy M, Masterson AV, Kerin M, Flanagan F. Pathology and clinical relevance of radial scars: a review. J Clin Pathol 2003; 56: 721-724.
Koker MM, Kleer CG. P63 expression in breast cancer. A highly sensitive and specific marker of metaplastic carcinoma. Am J Surg Pathol 2004; 28: 1506-1512.
Lagios MD, Westdahl PR, Margolin FR, Roses MR. Duct carcinoma in-situ; relationship of extent of non-invasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982; 50: 1309-1314.
Lee AHS, Denley HE, Pinder, SE, Ellis IO, Elston CW, Vujovic P, Macmillan RD, Evans AJ for the Nottingham Breast Team. Excision biopsy findings of patients with breast needle core biopsies reported as suspicious of malignancy (B4) or lesion of uncertain malignant potential (B3). Histopathology 2003; 42: 331-336.
Lerwill MF. Current practical applications of diagnostic immunohistochem-istry in breast pathology. Am J Surg Pathol 2004; 28: 1076-1091.
Lewis F, Jackson P, Lane S, Coast G, Hanby AM. Testing for HER 2 in breast cancer. Histopathology 2004; 45: 207-217.
Lloyd J, Flanagan AM. Mammary and extramammary Paget's disease. J Clin Pathol 2000; 53: 742-749.
Moffat CJC, Pinder SE, Dixon AR, Elston CW, Blamey RW, Ellis IO. Phyllodes tumours of the breast: a clinicopathological review of thirty-two cases. Histopathology 1995; 27: 205-218.
Nadji M, Gomez-Fernandez C, Ganjei-Azar P, Morales AR. Immunohisto-chemistry of estrogen and progesterone receptors reconsidered. Experience with 5993 cases. Am J Clin Pathol 2005; 123: 21-27.
NHSBSP publication no 50. June 2001. Guidelines for non-operative diagnostic procedures and reporting in breast cancer screening.
NHSBSP publication no 58. January 2005. Pathology reporting of breast disease. NHS Cancer Screening Programmes and The Royal College of Pathologists 2005.
Page DL, Anderson TJ. Diagnostic Histopathology of the Breast. Churchill Livingstone. Edinburgh 1987.
Pinder DL, Ellis IO, Galea M, O'Rourke S, Blamey RW, Elston CW. Pathological prognostic factors in the breast cancer. III Vascular invasion: relationship with recurrence and survival in a large study with long term follow-up. Histopathology 1994; 24: 41-47.
Pinder SE, Ellis IO, Elston CW. Prognostic factors in primary breast carcinoma. J Clin Pathol 1995; 48: 981-983.
Pinder SE, Elston CW, Ellis IO. The role of the pre-operative diagnosis in breast cancer. Histopathology 1996; 28: 563-566.
Quinn CM. The pathology of breast screening. Curr Diagn Pathol 2001; 7: 81-90.
Rosen's Breast Pathology, 2nd edn. Lippincott Williams and Wilkins. Philadelphia 2001.
Rosen PP. Breast Pathology: Diagnosis by Needle Core Biopsy. Lippincott Williams and Wilkins. Philadelphia 1999.
Rosen PP, Oberman HA. Tumors of the mammary gland. Atlas of tumor pathology. 3rd series. Fascicle 7. AFIP. Washington 1993.
Sainsbury JRC, Anderson TJ, Morgan DAL. ABC of breast diseases. Breast cancer. BMJ 2000; 321: 745-750.
Schnitt SJ. Columnar cell lesions of the breast: pathological features and clinical significance. Curr Diagn Pathol 2004; 10: 193-203.
Shousha S. Diagnosis of "early", "minimal" and impalpable breast carcinoma. Curr Diagn Pathol, 1994; 1: 90-97.
Shousha A. Reporting breast biopsies. Curr Diagn Pathol 2000; 6: 140-145.
Sloane JP, Lakhani SR. Atypical hyperplasias and DCIS: recognition and classification. CPD Bulletin Cellular Pathology 2000; 2: 72-75.
Smitt MC, Nowels KW, Zdeblick MJ et al. The importance of the lumpectomy surgical margin status in long-term results of breast conservation. Cancer 1995; 76: 259-267.
Tavassoli FA, Devilee P (eds). World Health Organization Classification of Tumours, Pathology and Genetics. Tumours of the Breast and Female Genital Organs. IARC Press. Lyon 2003.
Turner RR, Ollila DW, Stern S, Giulano A. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging. Am J Surg Pathol 1999; 23: 263-267.
UK National Coordinating Group for Breast Screening Pathology. Consistency of histopathological reporting of breast lesions detected by screening: findings of the UK National external quality assessment (EQA) scheme. Eur J Cancer 1994; 30: 1414-1419.
Van Diest PJ. Histopathological workup of sentinel lymph nodes: how much is enough? J Clin Pathol 1999; 52: 871-873.
Westenend PJ, Meurs CJC, Damhuis RAM. Tumour size and vascular invasion predict distant metastases in stage I breast cancer. Grade distinguishes early and late metastases. J Clin Pathol 2005; 58: 196-201.
Was this article helpful?
Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.